COVID-19 Impact on Global Romiplostim Market Size, Status and Forecast 2020-2026

July 2020 | 93 pages | ID: C855A2082B6DEN
QYResearch

Abstracts

This report focuses on the global Romiplostim status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Romiplostim development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• AMGEN

Market segment by Type, the product can be split into

• 250 ?g/0.5 mL
• 500 ?g/1 mL

Market segment by Application, split into

• Adults
• Pediatric patients

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Romiplostim status, future forecast, growth opportunity, key market and key players.
• To present the Romiplostim development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Romiplostim are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Romiplostim Revenue
1.4 Market Analysis by Type
  1.4.1 Global Romiplostim Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 250 ?g/0.5 mL
  1.4.3 500 ?g/1 mL
1.5 Market by Application
  1.5.1 Global Romiplostim Market Share by Application: 2020 VS 2026
  1.5.2 Adults
  1.5.3 Pediatric patients
1.6 Coronavirus Disease 2019 (Covid-19): Romiplostim Industry Impact
  1.6.1 How the Covid-19 is Affecting the Romiplostim Industry
    1.6.1.1 Romiplostim Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Romiplostim Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Romiplostim Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Romiplostim Market Perspective (2015-2026)
2.2 Romiplostim Growth Trends by Regions
  2.2.1 Romiplostim Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Romiplostim Historic Market Share by Regions (2015-2020)
  2.2.3 Romiplostim Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Romiplostim Market Growth Strategy
  2.3.6 Primary Interviews with Key Romiplostim Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Romiplostim Players by Market Size
  3.1.1 Global Top Romiplostim Players by Revenue (2015-2020)
  3.1.2 Global Romiplostim Revenue Market Share by Players (2015-2020)
  3.1.3 Global Romiplostim Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Romiplostim Market Concentration Ratio
  3.2.1 Global Romiplostim Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Romiplostim Revenue in 2019
3.3 Romiplostim Key Players Head office and Area Served
3.4 Key Players Romiplostim Product Solution and Service
3.5 Date of Enter into Romiplostim Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Romiplostim Historic Market Size by Type (2015-2020)
4.2 Global Romiplostim Forecasted Market Size by Type (2021-2026)

5 ROMIPLOSTIM BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Romiplostim Market Size by Application (2015-2020)
5.2 Global Romiplostim Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Romiplostim Market Size (2015-2020)
6.2 Romiplostim Key Players in North America (2019-2020)
6.3 North America Romiplostim Market Size by Type (2015-2020)
6.4 North America Romiplostim Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Romiplostim Market Size (2015-2020)
7.2 Romiplostim Key Players in Europe (2019-2020)
7.3 Europe Romiplostim Market Size by Type (2015-2020)
7.4 Europe Romiplostim Market Size by Application (2015-2020)

8 CHINA

8.1 China Romiplostim Market Size (2015-2020)
8.2 Romiplostim Key Players in China (2019-2020)
8.3 China Romiplostim Market Size by Type (2015-2020)
8.4 China Romiplostim Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Romiplostim Market Size (2015-2020)
9.2 Romiplostim Key Players in Japan (2019-2020)
9.3 Japan Romiplostim Market Size by Type (2015-2020)
9.4 Japan Romiplostim Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Romiplostim Market Size (2015-2020)
10.2 Romiplostim Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Romiplostim Market Size by Type (2015-2020)
10.4 Southeast Asia Romiplostim Market Size by Application (2015-2020)

11 INDIA

11.1 India Romiplostim Market Size (2015-2020)
11.2 Romiplostim Key Players in India (2019-2020)
11.3 India Romiplostim Market Size by Type (2015-2020)
11.4 India Romiplostim Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Romiplostim Market Size (2015-2020)
12.2 Romiplostim Key Players in Central & South America (2019-2020)
12.3 Central & South America Romiplostim Market Size by Type (2015-2020)
12.4 Central & South America Romiplostim Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 AMGEN
  13.1.1 AMGEN Company Details
  13.1.2 AMGEN Business Overview and Its Total Revenue
  13.1.3 AMGEN Romiplostim Introduction
  13.1.4 AMGEN Revenue in Romiplostim Business (2015-2020))
  13.1.5 AMGEN Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Romiplostim Key Market Segments
Table 2. Key Players Covered: Ranking by Romiplostim Revenue
Table 3. Ranking of Global Top Romiplostim Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Romiplostim Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of 250 ?g/0.5 mL
Table 6. Key Players of 500 ?g/1 mL
Table 7. COVID-19 Impact Global Market: (Four Romiplostim Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Romiplostim Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Romiplostim Players to Combat Covid-19 Impact
Table 12. Global Romiplostim Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Romiplostim Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Romiplostim Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Romiplostim Market Share by Regions (2015-2020)
Table 16. Global Romiplostim Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Romiplostim Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Romiplostim Market Growth Strategy
Table 22. Main Points Interviewed from Key Romiplostim Players
Table 23. Global Romiplostim Revenue by Players (2015-2020) (Million US$)
Table 24. Global Romiplostim Market Share by Players (2015-2020)
Table 25. Global Top Romiplostim Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Romiplostim as of 2019)
Table 26. Global Romiplostim by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Romiplostim Product Solution and Service
Table 29. Date of Enter into Romiplostim Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Romiplostim Market Size by Type (2015-2020) (Million US$)
Table 32. Global Romiplostim Market Size Share by Type (2015-2020)
Table 33. Global Romiplostim Revenue Market Share by Type (2021-2026)
Table 34. Global Romiplostim Market Size Share by Application (2015-2020)
Table 35. Global Romiplostim Market Size by Application (2015-2020) (Million US$)
Table 36. Global Romiplostim Market Size Share by Application (2021-2026)
Table 37. North America Key Players Romiplostim Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Romiplostim Market Share (2019-2020)
Table 39. North America Romiplostim Market Size by Type (2015-2020) (Million US$)
Table 40. North America Romiplostim Market Share by Type (2015-2020)
Table 41. North America Romiplostim Market Size by Application (2015-2020) (Million US$)
Table 42. North America Romiplostim Market Share by Application (2015-2020)
Table 43. Europe Key Players Romiplostim Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Romiplostim Market Share (2019-2020)
Table 45. Europe Romiplostim Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Romiplostim Market Share by Type (2015-2020)
Table 47. Europe Romiplostim Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Romiplostim Market Share by Application (2015-2020)
Table 49. China Key Players Romiplostim Revenue (2019-2020) (Million US$)
Table 50. China Key Players Romiplostim Market Share (2019-2020)
Table 51. China Romiplostim Market Size by Type (2015-2020) (Million US$)
Table 52. China Romiplostim Market Share by Type (2015-2020)
Table 53. China Romiplostim Market Size by Application (2015-2020) (Million US$)
Table 54. China Romiplostim Market Share by Application (2015-2020)
Table 55. Japan Key Players Romiplostim Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Romiplostim Market Share (2019-2020)
Table 57. Japan Romiplostim Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Romiplostim Market Share by Type (2015-2020)
Table 59. Japan Romiplostim Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Romiplostim Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Romiplostim Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Romiplostim Market Share (2019-2020)
Table 63. Southeast Asia Romiplostim Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Romiplostim Market Share by Type (2015-2020)
Table 65. Southeast Asia Romiplostim Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Romiplostim Market Share by Application (2015-2020)
Table 67. India Key Players Romiplostim Revenue (2019-2020) (Million US$)
Table 68. India Key Players Romiplostim Market Share (2019-2020)
Table 69. India Romiplostim Market Size by Type (2015-2020) (Million US$)
Table 70. India Romiplostim Market Share by Type (2015-2020)
Table 71. India Romiplostim Market Size by Application (2015-2020) (Million US$)
Table 72. India Romiplostim Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Romiplostim Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Romiplostim Market Share (2019-2020)
Table 75. Central & South America Romiplostim Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Romiplostim Market Share by Type (2015-2020)
Table 77. Central & South America Romiplostim Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Romiplostim Market Share by Application (2015-2020)
Table 79. AMGEN Company Details
Table 80. AMGEN Business Overview
Table 81. AMGEN Product
Table 82. AMGEN Revenue in Romiplostim Business (2015-2020) (Million US$)
Table 83. AMGEN Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Romiplostim Market Share by Type: 2020 VS 2026
Figure 2. 250 ?g/0.5 mL Features
Figure 3. 500 ?g/1 mL Features
Figure 4. Global Romiplostim Market Share by Application: 2020 VS 2026
Figure 5. Adults Case Studies
Figure 6. Pediatric patients Case Studies
Figure 7. Romiplostim Report Years Considered
Figure 8. Global Romiplostim Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Romiplostim Market Share by Regions: 2020 VS 2026
Figure 10. Global Romiplostim Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Romiplostim Market Share by Players in 2019
Figure 13. Global Top Romiplostim Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Romiplostim as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Romiplostim Revenue in 2019
Figure 15. North America Romiplostim Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Romiplostim Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Romiplostim Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Romiplostim Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Romiplostim Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Romiplostim Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Romiplostim Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. AMGEN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. AMGEN Revenue Growth Rate in Romiplostim Business (2015-2020)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed